Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C5H11NO2 |
| Molecular Weight | 117.1463 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)CCON=O
InChI
InChIKey=OWFXIOWLTKNBAP-UHFFFAOYSA-N
InChI=1S/C5H11NO2/c1-5(2)3-4-8-6-7/h5H,3-4H2,1-2H3
| Molecular Formula | C5H11NO2 |
| Molecular Weight | 117.1463 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
ISOPENTYL NITRITE (Amyl nitrite) is a chemical compound with an amyl group attached to the nitrite functional group. Amyl nitrite, in common with other alkyl nitrites, is a potent vasodilator; it expands blood vessels, resulting in lowering of the blood pressure. Alkyl nitrites are a source of nitric oxide, which signals for relaxation of the involuntary muscles. Physical effects include the decrease in blood pressure, headache, flushing of the face, increased heart rate, dizziness, and relaxation of involuntary muscles, especially the blood vessel walls and the internal and external anal sphincter. There are no withdrawal symptoms. Overdose symptoms include nausea, vomiting, hypotension, hypoventilation, shortness of breath, and fainting. The effects set in very quickly, typically within a few seconds and disappear within a few minutes. Amyl nitrite may also intensify the experience of synesthesia. Amyl nitrite is employed medically to treat heart diseases as well as angina. Amyl nitrite is sometimes used as an antidote for cyanide poisoning. It can act as an oxidant, to induce the formation of methemoglobin. Methemoglobin, in turn, can sequester cyanide as cyanomethemoglobin.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0042311 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | AMYL NITRITE Approved UseINDICATIONS AND USAGE: Amyl nitrite is indicated for the rapid relief of angina pectoris. Its effect appears within 30 seconds and lasts for approximately 3 to 5 minutes. |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator​
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 2.0 |
inconclusive [IC50 69.2463 uM] | |||
Page: 83.0 |
no | |||
Page: 121.0 |
no | |||
Page: 122.0 |
no | |||
Page: 121.0 |
no | |||
Page: 108.0 |
no | |||
Page: 11.0 |
no |
Drug as victim
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 107 | 110 |
no |
Tox targets
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 122.0 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| 2,6-Dichloro-pyridine-3,5-dicarbonitrile. | 2010-09-25 |
|
| Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains. | 2010-07-15 |
|
| Photolysis of n-butyl nitrite and isoamyl nitrite at 355 nm: a time-resolved Fourier transform infrared emission spectroscopy and ab initio study. | 2009-05-07 |
|
| A facile access to [60]fullerene-fused delta-lactones: unexpected reaction pathway of benzenediazonium-2-carboxylates controlled by organic bases. | 2009-04-07 |
|
| Formation of diazoate intermediate upon nitrous acid and nitric oxide treatment of 2'-deoxyadenosine. | 2009-02-01 |
|
| S-nitrosylated human serum albumin-mediated cytoprotective activity is enhanced by fatty acid binding. | 2008-12-12 |
|
| anti-Tricyclo-[4.2.1.1]deca-3,7-diene-9-endo,10-endo-diol. | 2008-11-08 |
|
| Aliphatic beta-nitro alcohols for non-enzymatic collagen cross-linking of scleral tissue. | 2008-09 |
|
| Design and evaluation of S-nitrosylated human serum albumin as a novel anticancer drug. | 2008-04 |
|
| Synthesis of alpha-oximinoketones under ultrasound irradiation. | 2008-04 |
|
| New modular and efficient approach to 6-substituted pyridin-2-yl C-nucleosides. | 2006-09-15 |
|
| Synthesis of peroxynitrite using isoamyl nitrite and hydrogen peroxide in a homogeneous solvent system. | 2006-07-15 |
|
| Nitrosation of sugar oximes: preparation of 2-glycosyl-1-hydroxydiazene-2-oxides. | 2005-12-23 |
|
| Synthesis of purin-2-yl carboxylate from O6-methylguanosine. | 2005 |
|
| Organic nitrites and NO: inhibition of lipid peroxidation and radical reactions. | 2004-02 |
|
| Inhibition of lipid peroxidation in synaptosomes and liposomes by nitrates and nitrites. | 2002-07 |
Sample Use Guides
Adults: 0.3 milliliter (1 ampul) taken by inhaling the vapor of amyl nitrite through the nose. Dose may be repeated within 1 to 5 minutes if pain is not relieved. If you still have chest pain after a total of 2 doses in a 10-minute period, contact your doctor or have someone take you to a hospital emergency room without delay.
Route of Administration:
Respiratory
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:04:28 GMT 2025
by
admin
on
Mon Mar 31 18:04:28 GMT 2025
|
| Record UNII |
5N0U5TUC9Z
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Mon Mar 31 18:04:28 GMT 2025 , Edited by admin on Mon Mar 31 18:04:28 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
7903
Created by
admin on Mon Mar 31 18:04:28 GMT 2025 , Edited by admin on Mon Mar 31 18:04:28 GMT 2025
|
PRIMARY | |||
|
DB01612
Created by
admin on Mon Mar 31 18:04:28 GMT 2025 , Edited by admin on Mon Mar 31 18:04:28 GMT 2025
|
PRIMARY | |||
|
m6438
Created by
admin on Mon Mar 31 18:04:28 GMT 2025 , Edited by admin on Mon Mar 31 18:04:28 GMT 2025
|
PRIMARY | Merck Index | ||
|
110-46-3
Created by
admin on Mon Mar 31 18:04:28 GMT 2025 , Edited by admin on Mon Mar 31 18:04:28 GMT 2025
|
PRIMARY | |||
|
203-770-8
Created by
admin on Mon Mar 31 18:04:28 GMT 2025 , Edited by admin on Mon Mar 31 18:04:28 GMT 2025
|
PRIMARY | |||
|
8053
Created by
admin on Mon Mar 31 18:04:28 GMT 2025 , Edited by admin on Mon Mar 31 18:04:28 GMT 2025
|
PRIMARY | |||
|
5N0U5TUC9Z
Created by
admin on Mon Mar 31 18:04:28 GMT 2025 , Edited by admin on Mon Mar 31 18:04:28 GMT 2025
|
PRIMARY | |||
|
606
Created by
admin on Mon Mar 31 18:04:28 GMT 2025 , Edited by admin on Mon Mar 31 18:04:28 GMT 2025
|
PRIMARY | |||
|
C87283
Created by
admin on Mon Mar 31 18:04:28 GMT 2025 , Edited by admin on Mon Mar 31 18:04:28 GMT 2025
|
PRIMARY | |||
|
C048958
Created by
admin on Mon Mar 31 18:04:28 GMT 2025 , Edited by admin on Mon Mar 31 18:04:28 GMT 2025
|
PRIMARY | |||
|
2691
Created by
admin on Mon Mar 31 18:04:28 GMT 2025 , Edited by admin on Mon Mar 31 18:04:28 GMT 2025
|
PRIMARY | |||
|
DTXSID9025455
Created by
admin on Mon Mar 31 18:04:28 GMT 2025 , Edited by admin on Mon Mar 31 18:04:28 GMT 2025
|
PRIMARY |